Aprea Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.28
|
-0.12
|
0.16
|
57.14%
|
|
2022-06-30
|
-0.37
|
-4.34
|
-3.97
|
-1072.97%
|
|
2022-03-31
|
-0.38
|
-0.36
|
0.02
|
5.26%
|
|
2021-12-31
|
-0.44
|
-0.36
|
0.08
|
18.18%
|
|
2021-09-30
|
-0.45
|
-0.45
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.47
|
-0.48
|
-0.01
|
-2.13%
|
|
2021-03-31
|
-0.49
|
-0.46
|
0.03
|
6.12%
|
|
2020-12-31
|
-0.64
|
-0.73
|
-0.09
|
-14.06%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.82
|
|
2021-12-31
|
-1.75
|
|
2020-12-31
|
-2.54
|
|
2019-12-31
|
-6.24
|